Douglasr Atkins News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BOSTON, April 24, 2024 Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells,.

United statesMarie campinellNataliya ubohaDouglasr atkinsJonathan pappasLifesci communicationsCue biopharma incCorporate communicationsCompany phaseWashington university school of medicineAmerican society of clinical oncologyAmerican societyClinical oncologyAnnual meetingWilm tumorBusiness update